-
In Iceland, the mystery of the poet, the tomb and the Danish grocer
-
Indonesia rescues second orangutan mother and baby from wildfire
-
Ratko Mladic: Bosnian Serb commander to convicted war criminal
-
Box office magnet Robert Pattinson appears in paedophile thriller
-
Bolivian army base blasts kill two, wound dozens
-
How haze from Indonesian fires impacts Southeast Asia
-
Alcaraz, Sabalenka into US Open last 16 as Williams sisters lose on return
-
Trump sends envoys to Moscow, Kyiv with new plan to 'end war'
-
Williams sisters fall in thrilling return to US Open doubles
-
'Mini-dictatorship': Students slam Argentina-run residence in Paris
-
Bangladesh measles toll nears grim 1,000-child mark
-
The disgraced banker stirring the pot in Brazil's Supreme Court
-
Bolivia farmers return to streets over diesel price hikes
-
Panama Canal begins reducing crossings due to El Nino
-
Tetris distances itself from controversial White House 'arcade' games
-
Trump again seeks to remove protections for wolves
-
Africa bigger, US smaller - UN adopts new map
-
'Getting there' - Alcaraz into US Open last 16 along with Sabalenka
-
Bad weather will not affect All Blacks, says captain Savea
-
Isak ready to show world his quality, says Van Dijk
-
Mbappe misses penalty as Parrott lifts Betis past Real Madrid
-
Stuttgart cruise past Cologne to bounce back from Bayern thumping
-
PSG still winless in Ligue 1 as Monaco go top
-
'Smart, aggressive' Alcaraz into US Open last 16
-
Defending champion Alcaraz reaches last 16 at US Open
-
Isak fires Liverpool to first win under Iraola at Ipswich
-
Lyles ends season before Budapest due to injury flare ups
-
Stocks slip as robust US jobs data stokes rate hike odds
-
US Republicans announce probe into environment groups
-
Mistrial declared in case of US woman who killed her three children
-
Sabalenka survives despite 'tricky' weed smell at US Open
-
Seville, Alfred win at Diamond League finals, Duplantis hit with injury
-
S&P Revises Outlook on Freedom Holding Corp. and Core Subsidiaries to Positive
-
Moody’s Assigns First-Time Insurance Financial Strength Ratings to Freedom Insurance and Freedom Life
-
Job growth but record-high diesel prices -- Trump's midterms mixed bag
-
Trump says envoys taking plan to 'end the war' to Moscow, Kyiv
-
Women's NBA comissioner Engelbert to retire at season's end
-
US Football Hall of Fame revamps selection process
-
Luis Enrique extends contract as PSG coach until 2030
-
Judge declares mistrial in case of US woman who killed her children
-
Duplantis pulls out of Diamond League finals
-
Edgar Davids art thief misses sentencing after being 'knocked out by luggage'
-
Defending champ Sabalenka, Pegula lead way into US Open fourth round
-
Pegula rallies to reach US Open fourth round
-
UK hard-right party rallies behind leader after new donation scandal
-
Defending champ Sabalenka leads way into US Open fourth round
-
Nigeria's Dangote refinery looks to raise $1.6 bn in IPO
-
Bayeux Tapestry 'virtually unchanged', UK museum says, after France spots broken threads
-
Portugal extends talks to privatise national carrier TAP
-
More than 120 killed in Yemen's worst clashes in years: sources
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
LAVAL, QC / ACCESS Newswire / February 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it will participate in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida on February 24. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.
Details
Date: | Monday, February 24, 2025 |
Time: | 8:45 a.m. U.S. EST |
Webcast: |
A replay of the event will be available on the investor relations website following the event.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Investor Contact: | Media Contact: |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
A.Clark--AT